• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型抗原捕获 ELISA 检测 SARS-CoV-2 的诊断性能。

Diagnostic performance of a novel antigen-capture ELISA for the detection of SARS-CoV-2.

机构信息

Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Anal Biochem. 2023 Apr 1;666:115079. doi: 10.1016/j.ab.2023.115079. Epub 2023 Feb 7.

DOI:10.1016/j.ab.2023.115079
PMID:36754135
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9902293/
Abstract

BACKGROUND AND AIMS

The coronavirus disease 2019 (COVID-19) pandemic is a serious health problem worldwide. Early virus detection is essential for disease control and management. Viral antigen detection by ELISA is a cost-effective, rapid, and accurate antigen diagnostic assay which could facilitate early viral detection.

METHOD

An antigen-capture sandwich ELISA was developed using novel nucleocapsid (NP)-specific mouse monoclonal antibodies (MAbs). The clinical performance of the assay was assessed using 403 positive and 150 negative respiratory samples collected during different SARS-CoV-2 variants outbreaks in Iran.

RESULTS

The limit of detection of our ELISA assay was found to be 43.3 pg/ml for recombinant NP. The overall sensitivity and specificity of this assay were 70.72% (95% CI: 66.01-75.12) and 100% (95% CI: 97.57-100), respectively, regardless of Ct values and SARS-CoV-2 variants. There was no significant difference in our assay sensitivity for the detection of Omicron subvariants compared to Delta variant. Assay sensitivity for the BA.5 Omicron subvariant was calculated as 91.89% (95% CI: 85.17-96.23) for samples with Ct values < 25 and 82.70% (95% CI: 75.19-88.71) for samples with Ct values < 30.

CONCLUSION

Our newly developed ELISA method is reasonably sensitive and highly specific for detection of SARS-CoV-2 regardless of the variants and subvariants of the virus.

摘要

背景与目的

2019 年冠状病毒病(COVID-19)大流行是全球严重的健康问题。早期病毒检测对于疾病控制和管理至关重要。酶联免疫吸附试验(ELISA)检测病毒抗原是一种经济有效、快速、准确的抗原诊断检测方法,有助于早期病毒检测。

方法

本研究使用新型核衣壳(NP)特异性鼠单克隆抗体(MAb)开发了抗原捕获夹心 ELISA。使用在伊朗不同 SARS-CoV-2 变体爆发期间收集的 403 份阳性和 150 份阴性呼吸道样本评估了该检测方法的临床性能。

结果

本 ELISA 检测方法的检测限为 43.3 pg/ml 重组 NP。无论 Ct 值和 SARS-CoV-2 变体如何,该检测方法的总灵敏度和特异性分别为 70.72%(95%CI:66.01-75.12)和 100%(95%CI:97.57-100)。与 Delta 变体相比,本研究检测 Omicron 亚变体的检测方法灵敏度没有显著差异。对于 Ct 值<25 的样本,BA.5 Omicron 亚变体的检测灵敏度计算为 91.89%(95%CI:85.17-96.23),对于 Ct 值<30 的样本,检测灵敏度为 82.70%(95%CI:75.19-88.71)。

结论

无论病毒的变体和亚变体如何,我们新开发的 ELISA 方法对于 SARS-CoV-2 的检测具有合理的灵敏度和高度特异性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6642/9902293/797a15590499/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6642/9902293/257d7b1f3ff4/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6642/9902293/fe7be00ae3e0/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6642/9902293/b0ecfa082348/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6642/9902293/14f336585e97/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6642/9902293/d598ed6ea7f3/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6642/9902293/797a15590499/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6642/9902293/257d7b1f3ff4/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6642/9902293/fe7be00ae3e0/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6642/9902293/b0ecfa082348/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6642/9902293/14f336585e97/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6642/9902293/d598ed6ea7f3/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6642/9902293/797a15590499/gr5_lrg.jpg

相似文献

1
Diagnostic performance of a novel antigen-capture ELISA for the detection of SARS-CoV-2.新型抗原捕获 ELISA 检测 SARS-CoV-2 的诊断性能。
Anal Biochem. 2023 Apr 1;666:115079. doi: 10.1016/j.ab.2023.115079. Epub 2023 Feb 7.
2
[Development and application of triple antibodies-based sandwich ELISA for detecting nucleocapsid protein of SARS-associated coronavirus].基于三联抗体的夹心酶联免疫吸附测定法检测严重急性呼吸综合征相关冠状病毒核衣壳蛋白的研制与应用
Zhonghua Liu Xing Bing Xue Za Zhi. 2005 Apr;26(4):277-81.
3
Production of a Monoclonal Antibody to the Nucleocapsid Protein of SARS-CoV-2 and Its Application to ELISA-Based Detection Methods with Broad Specificity by Combined Use of Detector Antibodies.生产针对 SARS-CoV-2 核衣壳蛋白的单克隆抗体,并结合使用检测抗体,在 ELISA 基础检测方法中实现广泛特异性的应用。
Viruses. 2022 Dec 21;15(1):28. doi: 10.3390/v15010028.
4
Early Laboratory Diagnosis of COVID-19 by Antigen Detection in Blood Samples of the SARS-CoV-2 Nucleocapsid Protein.早期通过检测 SARS-CoV-2 核衣壳蛋白在血液样本中的抗原诊断 COVID-19
J Clin Microbiol. 2021 Sep 20;59(10):e0100121. doi: 10.1128/JCM.01001-21. Epub 2021 Jul 14.
5
Characterization and application of a series of monoclonal antibodies against SARS-CoV-2 nucleocapsid protein.针对 SARS-CoV-2 核衣壳蛋白的一系列单克隆抗体的鉴定和应用。
J Med Virol. 2023 Jan;95(1):e28225. doi: 10.1002/jmv.28225. Epub 2022 Oct 25.
6
Development and Clinical Performance of InteliSwab COVID-19 Rapid Test: Evaluation of Antigen Test for the Diagnosis of SARS-CoV-2 and Analytical Sensitivity to Detect Variants of Concern Including Omicron and Subvariants.InteliSwab COVID-19 快速检测试剂的研发与临床性能:评估 SARS-CoV-2 抗原检测试剂的诊断性能及对包括奥密克戎及亚变种在内的关注变异株的分析灵敏度。
Viruses. 2023 Dec 29;16(1):61. doi: 10.3390/v16010061.
7
A novel highly specific biotinylated MAC-ELISA for detection of anti-SARS-CoV-2 nucleocapsid antigen IgM antibodies during the acute phase of COVID-19.一种新型高度特异性生物素化 MAC-ELISA,用于检测 COVID-19 急性期中抗 SARS-CoV-2 核衣壳抗原 IgM 抗体。
Braz J Microbiol. 2023 Dec;54(4):2893-2901. doi: 10.1007/s42770-023-01160-6. Epub 2023 Nov 6.
8
Development of monoclonal antibody-based blocking ELISA for detecting SARS-CoV-2 exposure in animals.基于单克隆抗体的阻断 ELISA 的开发,用于检测动物中 SARS-CoV-2 的暴露情况。
mSphere. 2023 Aug 24;8(4):e0006723. doi: 10.1128/msphere.00067-23. Epub 2023 Jul 6.
9
Design and Development of an Antigen Test for SARS-CoV-2 Nucleocapsid Protein to Validate the Viral Quality Assurance Panels.用于验证病毒质量保证面板的 SARS-CoV-2 核衣壳蛋白抗原检测试剂的设计与开发。
Viruses. 2024 Apr 24;16(5):662. doi: 10.3390/v16050662.
10
The development of a highly sensitive and quantitative SARS-CoV-2 rapid antigen test applying newly developed monoclonal antibodies to an automated chemiluminescent flow-through membrane immunoassay device.开发一种高灵敏度和定量的 SARS-CoV-2 快速抗原检测,应用新开发的单克隆抗体到自动化化学发光流动膜免疫分析设备上。
BMC Immunol. 2023 Sep 26;24(1):34. doi: 10.1186/s12865-023-00567-y.

引用本文的文献

1
Evolving Landscape of Emerging Virus Diagnosis: Challenges and Innovations.新兴病毒诊断的发展态势:挑战与创新
Mol Biotechnol. 2025 Mar 5. doi: 10.1007/s12033-025-01385-w.
2
Extracellular Vesicles as Biomarkers in Infectious Diseases.细胞外囊泡作为传染病中的生物标志物
Biology (Basel). 2025 Feb 11;14(2):182. doi: 10.3390/biology14020182.
3
Comprehensive Review of COVID-19: Epidemiology, Pathogenesis, Advancement in Diagnostic and Detection Techniques, and Post-Pandemic Treatment Strategies.新型冠状病毒肺炎(COVID-19)的全面综述:流行病学、发病机制、诊断和检测技术的进展,以及大流行后的治疗策略。

本文引用的文献

1
Epitope mapping of severe acute respiratory syndrome coronavirus 2 neutralizing receptor binding domain-specific monoclonal antibodies.严重急性呼吸综合征冠状病毒2中和性受体结合域特异性单克隆抗体的表位图谱分析
Front Med (Lausanne). 2022 Sep 6;9:973036. doi: 10.3389/fmed.2022.973036. eCollection 2022.
2
Impact of SARS-CoV-2 Omicron on Rapid Antigen Testing Developed for Early-Pandemic SARS-CoV-2 Variants.奥密克戎变异株对早期流行的 SARS-CoV-2 变异株快速抗原检测的影响。
Microbiol Spectr. 2022 Aug 31;10(4):e0200622. doi: 10.1128/spectrum.02006-22. Epub 2022 Aug 9.
3
Validation of the test for detecting SARS--CoV-2 antigens in the Polish population in patients with suspected SARS-CoV-2 infection.
Int J Mol Sci. 2024 Jul 26;25(15):8155. doi: 10.3390/ijms25158155.
4
Designing and expression of novel recombinant fusion protein for efficient antigen screening of SARS-CoV-2.用于高效筛选新型冠状病毒抗原的新型重组融合蛋白的设计与表达
AMB Express. 2024 Jul 11;14(1):80. doi: 10.1186/s13568-024-01719-y.
5
Development of a one-step reverse transcription-quantitative polymerase chain reaction assay for the detection of porcine reproductive and respiratory syndrome virus.建立一步法逆转录定量聚合酶链反应检测猪繁殖与呼吸综合征病毒。
PLoS One. 2023 Oct 16;18(10):e0293042. doi: 10.1371/journal.pone.0293042. eCollection 2023.
6
An update on lateral flow immunoassay for the rapid detection of SARS-CoV-2 antibodies.用于快速检测新型冠状病毒2抗体的侧向流动免疫分析的最新进展。
AIMS Microbiol. 2023 Apr 13;9(2):375-401. doi: 10.3934/microbiol.2023020. eCollection 2023.
在波兰疑似感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的人群中检测SARS-CoV-2抗原检测试验的验证
Cent Eur J Immunol. 2022;47(1):58-62. doi: 10.5114/ceji.2022.113992. Epub 2022 Feb 28.
4
Analytical Sensitivity of Six SARS-CoV-2 Rapid Antigen Tests for Omicron versus Delta Variant.六种 SARS-CoV-2 快速抗原检测试剂针对奥密克戎与德尔塔变异株的分析灵敏度比较。
Viruses. 2022 Mar 22;14(4):654. doi: 10.3390/v14040654.
5
Development of a sandwich enzyme-linked immunosorbent assay (ELISA) to quantify γ-glutamyl-carboxylated clotting factor IX and assess redox susceptibility of anticoagulant chemicals.建立一种夹心酶联免疫吸附测定法(ELISA)来定量 γ-谷氨酰羧化凝血因子 IX,并评估抗凝化学物质的氧化还原敏感性。
J Vet Med Sci. 2022 Jun 10;84(6):804-808. doi: 10.1292/jvms.22-0079. Epub 2022 Apr 20.
6
Epitope mapping of neutralising anti-SARS-CoV-2 monoclonal antibodies: Implications for immunotherapy and vaccine design.中和抗 SARS-CoV-2 单克隆抗体的表位作图:对免疫治疗和疫苗设计的影响。
Rev Med Virol. 2022 Sep;32(5):e2347. doi: 10.1002/rmv.2347. Epub 2022 Apr 8.
7
Choice of SARS-CoV-2 diagnostic test: challenges and key considerations for the future.SARS-CoV-2 诊断检测方法的选择:未来的挑战和关键考虑因素。
Crit Rev Clin Lab Sci. 2022 Nov;59(7):445-459. doi: 10.1080/10408363.2022.2045250. Epub 2022 Mar 15.
8
Impaired detection of omicron by SARS-CoV-2 rapid antigen tests.SARS-CoV-2 快速抗原检测对 omicron 的检测能力受损。
Med Microbiol Immunol. 2022 Jun;211(2-3):105-117. doi: 10.1007/s00430-022-00730-z. Epub 2022 Feb 20.
9
Diagnostics for COVID-19: moving from pandemic response to control.COVID-19 诊断:从大流行应对转向控制。
Lancet. 2022 Feb 19;399(10326):757-768. doi: 10.1016/S0140-6736(21)02346-1. Epub 2021 Dec 20.
10
A SARS-CoV-2 nucleocapsid ELISA represents a low-cost alternative to lateral flow testing for community screening in LMI countries.SARS-CoV-2 核衣壳 ELISA 检测法为中低收入国家的社区筛查提供了一种比侧向流动检测成本更低的替代方法。
J Infect. 2022 Jan;84(1):48-55. doi: 10.1016/j.jinf.2021.08.049. Epub 2021 Oct 1.